Myocardial revascularization and bilateral lung transplantation without cardiopulmonary bypass by Khatchatourian, Gregory et al.
Case report
Myocardial revascularization and bilateral lung transplantation without
cardiopulmonary bypassq
Gregory Khatchatouriana, Catherine Chevalleyb, Anastase Spiliopoulosc, Marc Lickerb,*
aClinics of Cardiovascular Surgery, University Hospital, 16 Rue Micheli-Ducrest, CH-1211 Geneva, Switzerland
bDepartment of Anesthesiology, Pharmacology and Surgical Intensive Care, University Hospital, 16 Rue Micheli-Ducrest, CH-1211 Geneva, Switzerland
cUnit of Thoracic Surgery, University Hospital, 16 Rue Micheli-Ducrest, CH-1211 Geneva, Switzerland
Received 22 May 2001; received in revised form 11 July 2001; accepted 14 July 2001
Abstract
Coronary artery disease is occasionally encountered in lung transplant recipients and is a risk factor for perioperative complications and
poor survival. Besides combined heart–lung transplantation, various techniques of myocardial revascularization can be performed before, or
at the time of lung transplantation. We report herein a patient with end-stage bronchoemphysema and two-vessel coronary disease who
underwent ‘off-pump’ coronary artery bypass graft immediately followed by bilateral lung transplantation.q 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Coronary artery disease (CAD) is documented in up to
17% patients referred for lung transplantation (LT) and is
traditionally considered an exclusion criterion [1]. Despite
these limitations, the International Lung Transplant Regis-
try reported a 5% perioperative mortality in lung transplant
recipients due to myocardial infarcts and 3% unexplained
sudden deaths where CAD could be a contributor [2].
Anecdotal reports have described combined heart–lung
transplantation, simultaneous CABG surgery and LT with
cardiopulmonary bypass (CPB) or a two-stage procedure
involving myocardial revascularization (prior to LT)
through percutaneous angioplasty (PTCA), conventional
CABG or a minimally invasive approach [3–5]. In this
report, we describe the first patient with end-stage chronic
obstructive pulmonary disease (COPD) and two-vessel
CAD who underwent ‘off-pump’ CABG and LT.
2. Case report
A 57-year-old man with a history of smoking presented
with end-stage COPD (forced expiratory volume in 1 s
(FEV1) of 1.7 l) and major limitations of exercise capacity
despite oxygen administration (100 m at 6-min walk test;
maximal oxygen consumption, 18% of predicted value).
During stress echocardiography, new wall motion
abnormalities were induced in the antero-apical part of the
left ventricle (LV), although a stent had been inserted in the
left anterior descending (LAD) artery 3 years previously.
The angiogram showed a moderately depressed systolic
LV function (LV ejection fraction, ,40%), an occluded
right coronary artery (RCA), and 70% stenosis of the
LAD artery that was not suitable for PTCA. Therefore,
the surgical plan was to perform simultaneous CABG and
LT on a ‘beating’ heart with a local donor in order to limit
the ischemia duration.
After anesthesia induction, a double-lumen tube was
inserted for selective pulmonary ventilation, and the
femoral vessels were prepared for eventual CPB and/or
intraaortic balloon pump. In addition to standard monitors,
an oximetric pulmonary artery catheter and transesophageal
echocardiography (TOE) were applied to assess the cardio-
vascular status. Normothermia was maintained by warming
i.v. fluids and using a thermostatic water mattress and a
forced warm air device.
Surgery proceeded through a clam-shell thoraco-sternal
incision. The target coronary artery was stabilized with a
mechanical retractor (Octopus, Medtronic, Minneapolis,
MN) and the territory of the LAD was ‘preconditioned’
by two short periods of complete ischemia (,2–3 min).
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Grafting of the LAD (with the left internal mammary artery,
22 min occlusion) and the RCA (with a saphenous vein, 20
min occlusion) was performed without circulatory dete-
rioration or ST/T segment changes.
Sequential LT was then performed in a 308 lateral tilted
position. Clamping of the left pulmonary artery produced
moderate pulmonary hypertension without further enlarge-
ment of the right ventricle or worsening of the tricuspid
regurgitation. Left and right pulmonary grafts were reper-
fused after ischemic durations of 120 and 220 min, respec-
tively. Positive end expiratory pressure (5–10 cmH2O) was
applied and nitroglycerine (0.5–2 mg/kg per min) was
continuously infused until the end of surgery.
The combined CABG and LT procedure lasted a total of
10 h and 30 min. Two units of red blood cell concentrates
were transfused to keep the hematocrit above 26%; i.v.
crystalloid and colloids (3.5 l) were infused to maintain
the circulatory volume while keeping the occluded pulmon-
ary arterial pressure below 12 mmHg.
Postoperatively, supraventricular arrhythmias were trea-
ted with i.v. amiodarone, and no myocardial injury was
detected (peak plasma troponin I, 0.9 mg/l). Weaning from
the ventilator was successful 18 h after surgery and pulmon-
ary gas exchange remained satisfactory thereafter
(PaO2 ¼ 16 kPa with an inspiratory O2 concentration
(FIO2) of 28%). An exercise rehabilitation program was
initiated and the patient was discharged home after a total
hospital stay of 29 days. At the 18-month follow-up, he was
able to exercise without angina, the FEV1 was increased at
85% of the predicted value, and the LV ejection had
improved from 40 to 55%.
3. Discussion
Cardiac testing is routinely performed in LT candidates
with two or more risks factors for CAD [2]. To improve
survival after LT, myocardial revascularization is recom-
mended when coronary stenosis is associated with ‘areas
at risk’ detected by dobutamine stress test or thallium-dipyr-
idamole scanning [6]. However, after conventional CABG
with hypothermic CPB, COPD patients are prone to develop
ventilator-associated bronchopneumonia as a result of
diaphragmatic dysfunction, atelectasis, pleural effusion
and interstitial lung edema [7]. Obviously, some patients
may benefit from PTCA or from lesser invasive revascular-
ization techniques (mini-thoracotomy) that minimize
respiratory-related morbidity [8].
In our patient, we elected to perform ‘open’ myocardial
revascularization immediately followed by LT since coron-
ary artery lesions were not amenable to PTCA. The decision
to proceed to a combined or separate cardiac–lung proce-
dure should take into account the severity of both cardiac
and pulmonary diseases, the general condition of the poten-
tial LT recipient, but also the available medical expertise on
‘off-pump’ coronary grafting and the necessity to have a
local donor in order to shorten lung ischemic time. Note-
worthy, patients with CAD may die from myocardial
infarcts in centers with long waiting lists, before suitable
heart–lung organs are proposed.
Intraoperatively, stabilization of the target coronary artery
with a mechanical retractor provided an immobile and blood-
less surgical field that obviated the need to slow the heart rate
with b-blockers. The use of an intracoronary shunt would
have been a suitable alternative to ischemic preconditioning.
Importantly, avoidance of CPB contributed to reduced bleed-
ing (due to anticoagulation and platelet dysfunction), and
possibly attenuated graft dysfunction since impaired
pulmonary vascular relaxation has been associated with the
inflammatory response to CPB [9]. Nitroglycerine — a nitric
oxide donor — that was given to attenuate myocardial ische-
mia, could also confer cytoprotective effects in the reper-
fused allograft via direct stimulation of the 3 0,5 0-cyclic
guanosine–monophosphate pathway [10].
The need for CPB could have been justified at different
steps of the surgical procedure: (1), unstable hemodynamic
conditions due to myocardial ischemia during clamping of
the LAD artery; (2), right ventricular failure secondary to
clamping of the pulmonary artery; (3), arrhythmias and/or
underfilling of the heart during surgical manipulations; (4),
impaired gas exchange during one-lung ventilation; (5),
acute graft dysfunction. Continuous monitoring with ECG,
TOE and an oximetric pulmonary artery catheter helped us
to detect and treat the early signs of cardiac and respiratory
disturbances.
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